Use of Erythropoietin as adjuvant therapy in nerve reconstruction

Langenbeck's Archives of Surgery

Volumn 393, Issue 3, 2008, Pages 317-323

  Lohmeyer, J A ^a,e   Essmann, E ^a   Richerson, S J ^b   Hagel, C ^c   Egana, J T ^a   Condurache, A ^d   Ganske, P ^b   Schulz, K ^b   Mailander P ^a   Machens, H G ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b MILWAUKEE SCHOOL OF ENGINEERING   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autologous nerve grafting; Digital cell analysis; Human recombinant Erythropoietin; Nerve conduit; Nerve regeneration

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE;

ADJUVANT THERAPY; ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; GASTROCNEMIUS MUSCLE; HISTOLOGY; INJECTION; LEG MUSCLE; LEWIS RAT; MORPHOMETRICS; MUSCLE ATROPHY; MUSCLE MASS; NERVE CELL; NERVE FIBER; NERVE RECONSTRUCTION; NERVE REGENERATION; NERVE TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TIBIA;

EID: 43349087775     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-008-0289-3     Document Type: Article

References (28)

1. 1. M Abrams J Widenfalk 2005 Emerging strategies to promote improved functional outcome after peripheral nerve injury Restor. Neurol. Neurosci. 23 367 382 16477099 Abrams M, Widenfalk J (2005) Emerging strategies to promote improved functional outcome after peripheral nerve injury. Restor. Neurol. Neurosci. 23:367–382
2. 2. FD Miller DR Kaplan 2001 Neurotrophin signalling pathways regulating neuronal apoptosis Cell Mol. Life Sci. 58 1045 1053 11529497 10.1007/PL00000919 1:CAS:528:DC%2BD3MXmvFWhsbo%3D Miller FD, Kaplan DR (2001) Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol. Life Sci. 58:1045–1053
3. 3. W Jelkmann 2007 Erythropoietin after a century of research: younger than ever Eur. J. Haematol. 78 183 205 17253966 10.1111/j.1600-0609.2007.00818.x 1:CAS:528:DC%2BD2sXjvFOitLc%3D Jelkmann W (2007) Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78:183–205
4. 4. MG Lykissas AV Korompilias MD Vekris GI Mitsionis E Sakellariou AE Beris 2007 The role of erythropoietin in central and peripheral nerve injury Clin. Neurol. Neurosurg. 109 639 644 17624659 10.1016/j.clineuro.2007.05.013 Lykissas MG, Korompilias AV, Vekris MD, Mitsionis GI, Sakellariou E, Beris AE (2007) The role of erythropoietin in central and peripheral nerve injury. Clin. Neurol. Neurosurg. 109:639–644
5. 5. WM Campana RR Myers 2001 Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury FASEB J 15 1804 1806 11481236 1:CAS:528:DC%2BD3MXmsFejs74%3D Campana WM, Myers RR (2001) Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J 15:1804–1806
6. 6. MG Lykissas E Sakellariou MD Vekris VA Kontogeorgakos AK Batistatou GI Mitsionis AE Beris 2007 Axonal regeneration stimulated by erythropoietin: an experimental study in rats J Neurosci. Methods 164 107 115 17532473 10.1016/j.jneumeth.2007.04.008 1:CAS:528:DC%2BD2sXmvVKls7g%3D Lykissas MG, Sakellariou E, Vekris MD, Kontogeorgakos VA, Batistatou AK, Mitsionis GI, Beris AE (2007) Axonal regeneration stimulated by erythropoietin: an experimental study in rats. J Neurosci. Methods 164:107–115
7. 7. K Jaquet K Krause M Tawakol-Khodai S Geidel KH Kuck 2002 Erythropoietin and VEGF exhibit equal angiogenic potential Microvasc. Res. 64 326 333 12204656 10.1006/mvre.2002.2426 1:CAS:528:DC%2BD38XmsV2ksrc%3D Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH (2002) Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc. Res. 64:326–333
8. 8. D Ribatti M Presta A Vacca R Ria R Giuliani P Dell'Era B Nico L Roncali F Dammacco 1999 Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Blood 93 2627 2636 10194442 1:CAS:528:DyaK1MXisVGktL8%3D Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627–2636
9. 9. PJ Evans SE Mackinnon R Midha JA Wade DA Hunter Y Nakao GM Hare 1999 Regeneration across cold preserved peripheral nerve allografts Microsurgery 19 115 127 10231120 10.1002/(SICI)1098-2752(1999)19:3<115::AID-MICR1>3.0.CO;2-9 1:STN:280:DyaK1M3ks1Wmsw%3D%3D Evans PJ, Mackinnon SE, Midha R, Wade JA, Hunter DA, Nakao Y, Hare GM (1999) Regeneration across cold preserved peripheral nerve allografts. Microsurgery 19:115–127
10. 10. E Barth T Caelli C Zetzche 1993 Image encoding, labeling, and reconstruction from differential geometry Graphical Model and Image Processing 55 428 446 Barth E, Caelli T, Zetzche C (1993) Image encoding, labeling, and reconstruction from differential geometry. Graphical Model and Image Processing 55:428–446
11. 11. Condurache A, Aach T (2005) Vessel segmentation in angiograms using hysteresis thresholding, Proceedings of the Ninth IAPR Conference on Machine Vision Applications (conference proceeding)
12. 12. Beucher, S (1997) Segmentation tools in mathematical morphology, HPRCV97 (conference proceeding)
13. 13. Richerson SJ, Condurache AP, Lohmeyer JA, Schultz K, Ganske P (2008) An initial approach to segmentation and analysis of nerve cells using ridge detection, Southwest Symposium on Image Analysis and Interpretation 2008 (conference proceeding)
14. 14. JB Jaquet AJ Luijsterburg S Kalmijn PD Kuypers A Hofman SE Hovius 2001 Median, ulnar, and combined median-ulnar nerve injuries: functional outcome and return to productivity J Trauma 51 687 692 11586160 1:STN:280:DC%2BD3Mrls1Krtw%3D%3D 10.1097/00005373-200110000-00011 Jaquet JB, Luijsterburg AJ, Kalmijn S, Kuypers PD, Hofman A, Hovius SE (2001) Median, ulnar, and combined median-ulnar nerve injuries: functional outcome and return to productivity. J Trauma 51:687–692
15. 15. SM Willerth SE Sakiyama-Elbert 2007 Approaches to neural tissue engineering using scaffolds for drug delivery Adv. Drug Deliv. Rev. 59 325 338 17482308 10.1016/j.addr.2007.03.014 1:CAS:528:DC%2BD2sXmtlShurY%3D Willerth SM, Sakiyama-Elbert SE (2007) Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Deliv. Rev. 59:325–338
16. 16. M Sakanaka TC Wen S Matsuda S Masuda E Morishita M Nagao R Sasaki 1998 In vivo evidence that erythropoietin protects neurons from ischemic damage Proc. Natl. Acad. Sci. U. S. A 95 4635 4640 9539790 10.1073/pnas.95.8.4635 1:CAS:528:DyaK1cXis1Ogsbo%3D Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U. S. A 95:4635–4640
17. 17. G Calapai MC Marciano F Corica A Allegra A Parisi N Frisina AP Caputi M Buemi 2000 Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation Eur. J. Pharmacol. 401 349 356 10936493 10.1016/S0014-2999(00)00466-0 1:CAS:528:DC%2BD3cXlsFCgtL0%3D Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, Buemi M (2000) Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 401:349–356
18. 18. X Li SL Gonias WM Campana 2005 Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury Glia 51 254 265 15812815 10.1002/glia.20202 Li X, Gonias SL, Campana WM (2005) Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia 51:254–265
19. 19. M Sugawa Y Sakurai Y Ishikawa-Ieda H Suzuki H Asou 2002 Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation Neurosci. Res. 44 391 403 12445627 10.1016/S0168-0102(02)00161-X 1:CAS:528:DC%2BD38XoslGhsLk%3D Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H (2002) Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci. Res. 44:391–403
20. 20. X Yu JJ Shacka JB Eells C Suarez-Quian RM Przygodzki B Beleslin-Cokic CS Lin VM Nikodem B Hempstead KC Flanders F Costantini CT Noguchi 2002 Erythropoietin receptor signalling is required for normal brain development Development 129 505 516 11807041 1:CAS:528:DC%2BD38Xht1Ojtbg%3D Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT (2002) Erythropoietin receptor signalling is required for normal brain development. Development 129:505–516
21. 21. SC Keswani U Buldanlioglu A Fischer N Reed M Polley H Liang C Zhou C Jack GJ Leitz A Hoke 2004 A novel endogenous erythropoietin mediated pathway prevents axonal degeneration Ann. Neurol. 56 815 826 15470751 10.1002/ana.20285 1:CAS:528:DC%2BD2MXit1Chuw%3D%3D Keswani SC, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, Zhou C, Jack C, Leitz GJ, Hoke A (2004) A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann. Neurol. 56:815–826
22. 22. WM Campana RR Myers 2003 Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury Eur. J Neurosci. 18 1497 1506 14511329 10.1046/j.1460-9568.2003.02875.x Campana WM, Myers RR (2003) Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur. J Neurosci. 18:1497–1506
23. 23. JA Lohmeyer ZL Shen GF Walter A Berger 2007 Bridging extended nerve defects with an artifcial nerve graft containing Schwann cells pre-seeded on polyglactin filaments Int. J Artif. Organs 30 64 74 17295194 1:STN:280:DC%2BD2s%2FpslWjsQ%3D%3D Lohmeyer JA, Shen ZL, Walter GF, Berger A (2007) Bridging extended nerve defects with an artifcial nerve graft containing Schwann cells pre-seeded on polyglactin filaments. Int. J Artif. Organs 30:64–74
24. 24. A Gorio N Gokmen S Erbayraktar O Yilmaz L Madaschi C Cichetti AM Giulio Di E Vardar A Cerami M Brines 2002 Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma Proc. Natl. Acad. Sci. U. S. A 99 9450 9455 12082184 10.1073/pnas.142287899 1:CAS:528:DC%2BD38XlsVGgt7o%3D Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, Brines M (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U. S. A 99:9450–9455
25. 25. ME Allaf A Hoke AL Burnett 2005 Erythropoietin promotes the recovery of erectile function following cavernous nerve injury J Urol. 174 2060 2064 16217394 10.1097/01.ju.0000176808.94610.dd 1:CAS:528:DC%2BD2MXhtV2rt7jL Allaf ME, Hoke A, Burnett AL (2005) Erythropoietin promotes the recovery of erectile function following cavernous nerve injury. J Urol. 174:2060–2064
26. 26. E Morishita S Masuda M Nagao Y Yasuda R Sasaki 1997 Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death Neuroscience 76 105 116 8971763 10.1016/S0306-4522(96)00306-5 1:CAS:528:DyaK28Xns1Wqu70%3D Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105–116
27. 27. C Juel JJ Thomsen RL Rentsch C Lundby 2007 Effects of prolonged recombinant human erythropoietin administration on muscle membrane transport systems and metabolic marker enzymes Eur. J. Appl. Physiol. 102 41 44 17882450 10.1007/s00421-007-0567-8 1:CAS:528:DC%2BD2sXht1OksLrM Juel C, Thomsen JJ, Rentsch RL, Lundby C (2007) Effects of prolonged recombinant human erythropoietin administration on muscle membrane transport systems and metabolic marker enzymes. Eur. J. Appl. Physiol. 102:41–44
28. 28. SY Fu T Gordon 1995 Contributing factors to poor functional recovery after delayed nerve repair: prolonged denervation J Neurosci. 15 3886 3895 7751953 1:CAS:528:DyaK2MXls1aisLk%3D Fu SY, Gordon T (1995) Contributing factors to poor functional recovery after delayed nerve repair: prolonged denervation. J Neurosci. 15:3886–3895